- Danaher Corporation
We’re Danaher - a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health
- Danaher Corporation - Wikipedia
Danaher Corporation is an American healthcare company headquartered in Washington, D C It develops products used for advances in biotechnology, life sciences, and diagnostics
- Jim Cramer has faith in Danahers turnaround as life sciences . . . - CNBC
Life sciences stocks are seeing a resurgence — and that's good news for Danaher
- Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair . . .
Read here for the latest Danaher stock analysis: buy rating, 10 5% upside, and growth driven by biotech See if DHR stock's premium is justified
- Danaher Corporation (NYSE:DHR) Is Going Strong But Fundamentals Appear . . .
Most readers would already be aware that Danaher's (NYSE:DHR) stock increased significantly by 11% over the past three
- Our Businesses | Danaher Companies
Danaher is comprised of more than 15 diverse businesses across Biotechnology, Diagnostics, and Life Sciences Learn more about the Danaher companies
- Danaher Sweetens the Pot: Board Approves $0. 32 Quarterly Cash Dividend . . .
Danaher Corporation's approval of a $0 32 per share quarterly cash dividend is a significant event that underscores the company's robust financial health and unwavering commitment to its shareholders
- Danaher (DHR) Company Profile Description - Stock Analysis
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally
|